Understanding Colorectal Cancer

Introduction

Colorectal cancer refers to cancer that begins in the colon or rectum, both of which are parts of the large intestine. It typically develops from precancerous growths called polyps that can become malignant over time if not detected and removed. While colorectal cancer is highly treatable when caught early, it's also one of the most commonly diagnosed cancers in the United States. With rising rates among younger adults and changing patterns of risk, it’s essential to understand what colorectal cancer is, who is affected, and what treatment and integrative care options are available.

Demographics

Colorectal cancer is the third most commonly diagnosed cancer and the second leading cause of cancer-related deaths in the U.S. Historically, it has primarily affected individuals over the age of 50, but recent data from the American Cancer Society shows a concerning rise in cases among adults under 55. In fact, about 1 in 5 colorectal cancers are now diagnosed in people under 55, compared to 1 in 10 in the mid-1990s. Men have a slightly higher risk than women, and African American and Native American populations face disproportionately higher incidence and mortality rates.

Causes and Risk Factors

While the exact cause of colorectal cancer can vary from person to person, several risk factors have been identified:

• Age (especially over 50, however there has been a significant risk in young adults in recent years )

• Family history of colorectal cancer or inherited syndromes (like Lynch syndrome and Familial Adenomatous Polyposis)

• Inflammatory bowel diseases such as Crohn’s disease or ulcerative colitis

• Poor diet (high in red and processed meats, low in fiber)

• Physical inactivity

• Obesity

• Smoking and heavy alcohol use

• Type 2 diabetes

• Microbiome imbalance and chronic inflammation 

More recent studies suggest that lifestyle and environmental exposures, including poor gut health, chronic stress, and metabolic dysfunction, may also play a significant role.

Signs and Symptoms

Colorectal cancer can be asymptomatic in its early stages, which makes screening critically important. As the disease progresses, common signs and symptoms may include:

• Blood in the stool (bright red or very dark)

• Persistent abdominal discomfort or cramping

• Changes in bowel habits (constipation or diarrhea)

• Narrow stools

• Unintended weight loss

• Fatigue or weakness

• A feeling that the bowel doesn’t completely empty

• Any persistent gastrointestinal changes should be evaluated, especially for individuals with multiple risk factors

Conventional Treatment Options

Treatment for colorectal cancer depends on the stage of the disease, tumor location, and overall health of the patient. Common options include:

• Surgery: Often the first step for early-stage colorectal cancer, surgery aims to remove cancerous tissue and nearby lymph nodes

• Chemotherapy: Used to destroy cancer cells that may remain after surgery or to treat advanced cancer

• Radiation therapy: Often used in rectal cancer to shrink tumors before surgery or to manage symptom

• Targeted therapies: Drugs like bevacizumab or cetuximab that interfere with cancer cell growth

• Immunotherapy: Emerging treatments, especially for cancers with high microsatellite instability (MSI-H) or mismatch repair deficiency (dMMR)

Integrative Care

Integrative oncology combines conventional treatments with supportive therapies to reduce side effects, enhance quality of life, and support the body’s natural healing. For individuals with colorectal cancer, integrative care may include:

• Nutrition therapy to support digestion, immunity, and metabolism

• Acupuncture to manage pain, fatigue, nausea, neuropathy, and many other side-effects

• Herbal medicine to support detoxification and reduce inflammation (when safe and appropriate)

• Mind-body practices like exercise, meditation, and breathwork to reduce stress and promote emotional healing

• Functional medicine to address underlying imbalances in gut health, inflammation, and hormone regulation

Please note that these therapies should always be personalized and coordinated with your oncology team to ensure safety and effectiveness.

Prognosis

When detected early, colorectal cancer has a very high survival rate. According to the American Cancer Society:

• The 5-year survival rate for localized colorectal cancer (confined to the colon or rectum) is around 91%.

• For cancer that has spread to regional lymph nodes, the rate drops to 72%.

• For metastatic colorectal cancer (spread to distant organs), the 5-year survival rate is around 13%, though outcomes continue to improve with newer treatments and integrative support.

Prognosis is also influenced by the patient's overall health, tumor biology, response to treatment, and access to comprehensive care.

Conclusion

Understanding colorectal cancer is the first step in reducing your risk and improving outcomes after diagnosis. With early detection, appropriate treatment, and integrative support, many people go on to lead full, healthy lives. Whether you're looking to prevent disease, manage a diagnosis, or support a loved one, empowering yourself with knowledge and partnering with a team that addresses the whole person can improve quality of life, enhance recovery, and reduce the risk of recurrence in the future.